Business · 04/02/1994Updated: 10/15/2026 · 1 min read
Albuquerque Substance Abuse Clinic; Denial of Hearing and Revocation of Approval of a Narcotic Addiction Treatment Program; Final Order
Summary
The Food and Drug Administration (FDA) is revoking approval of Albuquerque Substance Abuse Clinic's (ASAC) methadone treatment program due to failure to correct and prevent violations of FDA's regulation, and denying their request for a hearing.
Original source language: Federal Register — Health and Human ServicesOpen original release →